Clinical trial
Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By…
NCT00357617 · Centre Hospitalier Universitaire Vaudois, Other · Unknown status
Key facts
| NCT number | NCT00357617 |
|---|---|
| Title | Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery |
| Official title | Evaluation of the Effect of Celecoxib on Angiogenesis Markers in Patients With Operable Head and Neck Squamous Cell Carcinoma |
| Lead sponsor | Centre Hospitalier Universitaire Vaudois, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Genetic, Other, Procedure |
| Interventions | celecoxib, microarray analysis, protein expression analysis, immunoenzyme technique, immunohistochemistry staining method, laboratory biomarker analysis, biopsy, conventional surgery, neoadjuvant therapy |
| Enrollment | 24 |
| Start date | Jun 1, 2006 |
| First posted | Jul 27, 2006 |
| Last update posted | Dec 24, 2010 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: